InvestorsHub Logo
Followers 21
Posts 635
Boards Moderated 0
Alias Born 11/08/2018

Re: Pharmacydude post# 381499

Wednesday, 06/29/2022 2:28:47 AM

Wednesday, June 29, 2022 2:28:47 AM

Post# of 425772
Pharmacydude
Amarin is a great drug - you are as well versed as anyone as to its present clinical value -and it’s applications may well expand over time
As to the value of the company that has been damaged by the company itself through foolishly conducted litigation and the equally foolish conviction of the self rewarding board (in its various guises) that GIA could be a runaway success (albeit outside factors such as covid which could not be predicted have made GIA even worse in performance )
Whilst any drug company with a developed product has to GIA until it is not (by the company being sold) it has been the gross mismanagement and unrealistic BO value in my view that has damned the SP to its present levels

A parsimonious low cost GIA was required and a low cost board operation (instead of vastly unrealistic share option and other rewards) whilst being open to BO opportunities at realistic levels
Could this company be sold tomorrow- of course it could - make the BO price low enough and a big pharma would buy

This board has never opened a realistic BO approach in my view
There has been in simple terms appalling company management and we are presently saddled with that

That is why Denner is our best hope of the required knife cutting change that is desperately required

The company needs to cut its costs to the bone and put up a big for sale sign at best and final offers

It’s the only way this drug will over time serve its purpose
And the only way we will be released from this misery(albeit at low levels of value )

I still hope one day to get back to a value equivalent to 10 dollars a share but it could take quite a while yet

The day to day trading of the share for possible micro profits has no real place in the bigger picture of where the SP will go

About the only thing you can say today is the SP probably won’t go much lower

We have little choice but to sit it out and let’s hope Denner sends a cruise missile into the boardroom
Alm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News